Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On January 3, 2022, Repligen Corporation (the "Company") promoted James Bylund,
the Company's current Senior Vice President, Operations and Information
Technologies, to the role of Chief Operating Officer of the Company, effective
January 1, 2022. In connection with this promotion, Mr. Bylund was also
appointed by the Company to serve as the Company's principal operating officer.
Mr. Bylund joined the Company in March 2020 as Senior Vice President, Operations
and Information Technologies, responsible for overseeing all operations and
information technology functions on a global basis. Prior to joining the
Company, Mr. Bylund spent ten years at Thermo Fisher Scientific in a number of
roles including Vice President and General Manager of the Single Use
Technologies Business Unit and Vice President of Global Operations for the
Bioproduction Division. Prior to joining Thermo Fisher, Mr. Bylund also worked
for Fiserv (9 years) and Eli Lilly and Company (7 years) in a variety of
leadership roles. He holds a B.S in Accounting from Utah State University and an
M.B.A. from Indiana University.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit No. Description
104 Cover page from this Current Report on Form 8-K, formatted in
Inline XBRL
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses